Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 09 Feb 2024 for Compass Therapeutics, Inc., €66k. Read the official filing
Filing timeline
BuySaleVered Bisker-Leib
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Vered Bisker-Leib: trading record in brief
Vered Bisker-Leib is a declared insider of Compass Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 16 November 2021 and 8 February 2024, the trades on record add up to 7 filings.
No open-market purchase appears, only 2 sales worth €87k. The rest of the record consists of 5 share grants.
The newest entry dates from 9 February 2024: a share grant of €66k, in Compass Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vered Bisker-Leib
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
49,198 shares@ US$1.452.0% of flowCommon StockSEC:0001171843-24-000715:0
1,753,125 shares@ US$1.9392.7% of flowCommon StockSEC:0001171843-24-000179:0
64,415 shares@ US$1.502.7% of flowCommon StockSEC:0001171843-23-007223:0
400,000 shares0Common StockSEC:0001171843-23-000846:0
14,929 shares@ US$4.191.8% of flowCommon StockSEC:0001171843-22-007662:0
6,226 shares@ US$4.400.8% of flowCommon StockSEC:0001171843-22-007635:0
600,000 shares0Common StockSEC:0000899243-21-045309:0
7 of 7 declarations
